These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26888282)

  • 1. In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.
    Franz F; Angerer V; Brandt SD; McLaughlin G; Kavanagh PV; Moosmann B; Auwärter V
    Drug Test Anal; 2017 Feb; 9(2):311-316. PubMed ID: 26888282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthesis and characterization of the 'research chemical' N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer.
    McLaughlin G; Morris N; Kavanagh PV; Power JD; Twamley B; O'Brien J; Talbot B; Dowling G; Brandt SD
    Drug Test Anal; 2016 Sep; 8(9):920-9. PubMed ID: 26360802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
    Li J; Liu C; Li T; Hua Z
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tentative identification of the metabolites of (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods.
    Grigoryev A; Kavanagh P; Labutin A; Pechnikov A; Dowling G; Shevyrin V; Krupina N
    Drug Test Anal; 2019 Sep; 11(9):1387-1402. PubMed ID: 31243890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
    Carlier J; Diao X; Huestis MA
    J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?
    Franz F; Angerer V; Hermanns-Clausen M; Auwärter V; Moosmann B
    Anal Bioanal Chem; 2016 May; 408(13):3445-52. PubMed ID: 26935933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
    Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
    Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
    Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
    Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspect and non-target screening workflows to investigate the in vitro and in vivo metabolism of the synthetic cannabinoid 5Cl-THJ-018.
    Vervliet P; Mortelé O; Gys C; Degreef M; Lanckmans K; Maudens K; Covaci A; van Nuijs ALN; Lai FY
    Drug Test Anal; 2019 Mar; 11(3):479-491. PubMed ID: 30242979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolism of the synthetic cannabinoids PX-1, PX-2, and PX-3 by high-resolution mass spectrometry and their clearance rates in human liver microsomes.
    Cooman T; Bell S
    Rapid Commun Mass Spectrom; 2019 Dec; 33(23):1816-1825. PubMed ID: 31364227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicokinetics of new psychoactive substances: plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS/MS.
    Mardal M; Gracia-Lor E; Leibnitz S; Castiglioni S; Meyer MR
    Drug Test Anal; 2016 Oct; 8(10):1039-1048. PubMed ID: 26810883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3).
    Presley BC; Logan BK; Jansen-Varnum SA
    J Anal Toxicol; 2020 Apr; 44(3):226-236. PubMed ID: 31665324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.